Saving changes...

Done

Error

Introduction to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition

Introduction to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition

Introduction to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition

Erin Hohman, PharmD.
Erin Hohman, PharmD.
on behalf of ProCE Inc.

FREE
FREE
FREE

FREE
FREE
FREE

null FREE
FREE
FREE
null FREE
FREE
FREE
Normal Price: FREE FREE

Review:

Launch date: 08 Mar 2017
Expiry Date:

Last updated: 13 Mar 2017

Reference: 170934

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE) website. CSPE is the educational hub of the National Association of Specialty Pharmacy (NASP). Most CSPE activities include the pathophysiology and clinical therapeutics of various disease states in which specialty pharmacy products and services are provided. CSPE also covers legal, regulatory and operational topics relevant to specialty pharmacy practice.

Objectives

Objectives
Learning Objectives:The target audience for this activity is pharmacists. Upon completion of this activity, participants will be able to:Discuss the pathophysiology of hypercholesterolemia.Discuss current treatments of hypercholesterolemia.Describe the function of PCSK9 in the body and how inhibition can affect low-density lipoprotein cholesterol (LDL-C) levels in the blood.Outline the Food and Drug Administration (FDA) approved indications, dosing, administration and adverse effects of alirocumab and evolocumab.Summarize clinical studies involving alirocumab and evolocumab.List pipeline molecules influencing PCSK9.
Erin Hohman, PharmD.

Author Information Play Video Bio

Erin Hohman, PharmD.
on behalf of ProCE Inc.

Erin Hohman, PharmD., BCPS Director of Clinical Pharmacy Services Amber Pharmacy Omaha, Nebraska

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 0.80 Hours -
    Exam Pass Rate: 75
    -
    Reference: 0221-9999-15-262-H04-P

Faculty and Disclosures

Additional Contributors

null

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error